Cargando…

TLR9 Ligand Induces the Generation of CD20+ Plasmablasts and Plasma Cells from CD27+ Memory B-Cells

Plasma cells (PCs) have a heterogeneous phenotype in humans. While bone marrow PCs are CD20−CD138+, tonsil PCs are CD20+CD138+/− and peripheral plasmablasts (PBs) are CD20−CD138−. In vitro, PCs are mainly generated by the activation of CD27+ memory B-cells through transient stimulation of CD40, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geffroy-Luseau, Alexandrine, Chiron, David, Descamps, Géraldine, Jégo, Gaëtan, Amiot, Martine, Pellat-Deceunynck, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342082/ https://www.ncbi.nlm.nih.gov/pubmed/22566872 http://dx.doi.org/10.3389/fimmu.2011.00083

Ejemplares similares

Targeting Oxidative Stress With Auranofin or Prima-1(Met) to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells
por: Tessoulin, Benoit, et al.
Publicado: (2019)

Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma
por: Chiron, David, et al.
Publicado: (2015)

BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker
por: Tessoulin, Benoît, et al.
Publicado: (2019)

Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells
por: Gillardin, Pierre-Samuel, et al.
Publicado: (2017)

Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways
por: Tessoulin, Benoît, et al.
Publicado: (2018)

Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells
por: Chiron, D, et al.
Publicado: (2013)

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma
por: Hanf, Matthieu, et al.
Publicado: (2016)

Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes
por: Seiller, Carolane, et al.
Publicado: (2020)

CD27(hi)CD38(hi) plasmablasts are activated B cells of mixed origin with distinct function
por: Rouers, Angeline, et al.
Publicado: (2021)

Responses of CD27(+)CD38(+) plasmablasts, and CD24(hi)CD27(hi) and CD24(hi)CD38(hi) regulatory B cells during primary dengue virus 2 infection
por: Lei, Chenshuang, et al.
Publicado: (2021)

Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis
por: Bustany, Sophie, et al.
Publicado: (2015)

RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53(abnormal) myeloma cells independently of the p53 pathway
por: Surget, Sylvanie, et al.
Publicado: (2014)

Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups
por: Gomez-Bougie, Patricia, et al.
Publicado: (2014)

BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival
por: Champion, Ophélie, et al.
Publicado: (2023)

Gut-Homing Conventional Plasmablasts and CD27(−) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans
por: Toapanta, Franklin R., et al.
Publicado: (2014)

Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma
por: Kervoëlen, Charlotte, et al.
Publicado: (2015)

BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma
por: Bodet, L, et al.
Publicado: (2010)

The Origin of the Plasma-Cell Heterogeneity
por: Pellat-Deceunynck, Catherine, et al.
Publicado: (2015)

Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK
por: Brosseau, C, et al.
Publicado: (2014)

The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction
por: Descamps, G, et al.
Publicado: (2012)

Circulating (CD3(−)CD19(+)CD20(−)IgD(−)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
por: Pozdzik, Agnieszka, et al.
Publicado: (2016)

Post-Transplant Lymphoproliferative Disorder Presenting as CD20-Negative Plasmablastic Lymphoma in the Lung
por: Kaleem, Tasneem, et al.
Publicado: (2016)

CD-20 Negative Plasmablastic Lymphoma Lurking in the Shadow of a Leiomyoma – Diagnosis and Management
por: Bindra, Bikramjit S, et al.
Publicado: (2019)

Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells
por: Covens, Kris, et al.
Publicado: (2023)

Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition
por: Arumugakani, Gururaj, et al.
Publicado: (2017)

Plasmablastic plasma cell myeloma mimicking plasmablastic lymphoma
por: Choi, Qute, et al.
Publicado: (2010)

Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease
por: Lodé, L, et al.
Publicado: (2013)

Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma
por: Maïga, S, et al.
Publicado: (2013)

TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells
por: Ghamlouch, Hussein, et al.
Publicado: (2014)

Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis
por: Agarbati, S., et al.
Publicado: (2022)

The nature of circulating CD27(+)CD43(+) B cells
por: Perez-Andres, Martin, et al.
Publicado: (2011)

An Advanced AIDS Patient With CD4 <20 and Plasmablastic Lymphoma Achieving Complete Response With the V-EPOCH Regimen
por: Nelson, Blessie, et al.
Publicado: (2020)

Multimeric forms of CD40 ligand (CD40L), 4-1BB ligand (4-1BBL), OX40 ligand (OX40L), CD27L/CD70, and other TNFSFs as tools for adoptive cell therapy
por: Kornbluth, Richard S
Publicado: (2013)

Expression and Function of TLR2 on CD4 Versus CD8 T Cells
por: Lee, Sun-Mi, et al.
Publicado: (2009)

Decreased levels of T follicular helper (CD4+CXCR5+) cells and CD27+CD38+ and CD27+CD38− B cells in ankylosing spondylitis patients correlate with markers of inflammation
por: Lejon, Kristina, et al.
Publicado: (2022)

A humanised anti-IGF-1R monoclonal antibody (AVE1642) enhances Bortezomib-induced apoptosis in myeloma cells lacking CD45
por: Descamps, G, et al.
Publicado: (2009)

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20(+)CD27(+)CD43(+)CD70(−)
por: Griffin, Daniel O., et al.
Publicado: (2011)

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20(+)CD27(+)CD43(+)CD70(−)
por: Griffin, Daniel O., et al.
Publicado: (2011)

Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20(+)CD27(+)CD43(+)CD70(−)
por: Griffin, Daniel O., et al.
Publicado: (2011)

Activated CD27+ and CD27- memory B cells accumulate in the joints of patients with juvenile idiopathic arthritis
por: Morbach, H, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_runspe06uis6ldqh7v07morl3c